For 20 years, the Anglonordic Life Science Conference has served as a bridge between European investors, connecting pioneering R&D companies across Northern and other parts of Europe.
Over 370 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, attended the 20th Anniversary Anglonordic Life Science Conference.
With over 90 investment firms participating, on-point panel discussions and 36 funding pitches presented by cutting-edge biomedical and healthcare startups, this was the culmination of the conference's 2 decades as a unique R&D-to-investor conference in the UK.
Register your place for the 21st Anglonordic Life Science Conference.